Polycin® Ointment
Bacitracin / Polymyxin B · ophthalmic ointment
Antibiotic
Approved uses
Superficial bacterial infection of the external eye and adnexa: conjunctivitis, keratitis, keratoconjunctivitis, blepharitis, blepharoconjunctivitis
Apply every 3 or 4 hours for 7 to 10 days, depending on severity of the infection
Contraindications
Hypersensitivity to any component of the product.
Ophthalmic ointment, 3.5 g (1/8 oz) sterile tamper evident tube with ophthalmic tip, bacitracin zinc 500 units per gram, polymyxin B sulfate 10,000 units per gram
Bacitracin interferes with bacterial cell wall synthesis by inhibiting regeneration of the phospholipid receptors involved in peptidoglycan synthesis, and is bactericidal for a variety of gram-positive and gram-negative organisms. Polymyxin B is bactericidal for a variety of gram-negative organisms, increasing bacterial cell membrane permeability by interacting with the membrane phospholipids; the two spectra overlap to give a wide range of antibacterial action.
Warnings & Precautions
- Not for injection: Not for injection into the eye, and should never be directly introduced into the anterior chamber of the eye.
- Corneal wound healing: Ophthalmic ointments may retard corneal wound healing.
- Cutaneous sensitization: Topical antibiotics may cause cutaneous sensitization, and a precise incidence of hypersensitivity reactions (primarily skin rash) is not known; manifestations are usually itching, reddening, and edema of the conjunctiva and eyelid.
- Failure to heal: A sensitization reaction may manifest simply as a failure to heal. During long-term use, periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed; application of products containing these ingredients should be avoided thereafter.
- Allergic cross-reactions: Allergic cross-reactions may occur which could prevent the use of any or all of the following antibiotics for the treatment of future infections: kanamycin, paromomycin, streptomycin, and possibly gentamicin.
- Superinfection and resistance: Prolonged use may result in overgrowth of non susceptible organisms including fungi; if superinfection occurs, appropriate measures should be initiated. Bacterial resistance may also develop.
- Aggravated discharge, inflammation, or pain: If purulent discharge, inflammation, or pain become aggravated, the patient should discontinue use and consult a physician.
- Bacterial keratitis: Bacterial keratitis has been reported after inadvertent patient contamination of multiple-dose topical ophthalmic containers, most of those patients having concurrent corneal disease or a disrupted ocular epithelial surface.
Common Side Effects
Allergic sensitization reactions, including itching, swelling, and conjunctival erythema, occur most often; the exact incidence is not known. Local irritation on instillation has also been reported. More serious hypersensitivity reactions, including anaphylaxis, have been reported rarely.
Pregnancy: Category C; animal reproduction studies have not been conducted with either component and fetal harm potential is unknown, so give only if clearly needed.
Lactation: Excretion in human milk is unknown, so caution is warranted in a nursing woman.
Safety and effectiveness in pediatric patients have not been established.